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The term “epigenetics” has been widely used and abused [1] but the most compelling 
definition of epigenetics is the study of changes in gene function that are heritable through 
cell division, yet reversible, and that do not involve changes in DNA sequence - with 
heritability and reversibility being the key factors. Epigenetic information persists after the 
original inductive process that drove the modification has ceased, providing a cellular 
memory of the process or exposure in subsequent generations. Epigenetic marks allow the 
cell to remember what kind of cell it is irrespective of positional information and other 
extracellular information. Parent cells use epigenetic marks to “tell” their daughter cells what 
type of cell they will become, a message that may persist through thousands of cell divisions 
for the lifetime of the organism, unless they are actively erased or lost through epimutation. 
Epigenetic processes are fundamentally important for cell identity, lineage determination, 
regeneration and re-establishing of the next generation. They explain how an identical set 
of genomic instructions can generate all the required cell types for the organism without the 
need, in most cases, to alter gene sequence.  
The heritability through mitosis of the epigenetic information is relatively well characterised 
and acknowledged by the scientific community. Studies in various organisms, including 
plants and nematodes, have also revealed that epigenetic traits can be propagated through 
meiosis i.e. from one generation to the next. There is, however, much debate as to whether 
this holds true in mammals. The reason behind this questioning is the extensive epigenetic 
reprogramming that occurs twice in mammalian life, namely during the formation of the 
gametes and, after their fusion, in the embryo to be implanted. These events lead to an a 
priori complete (and this is where part of the debate stands) erasure of the epigenetic 
information that has been acquired during the parent’s life, so that the new generation starts 
with a “clean slate”. In addition, it is difficult to confidently assign the heritability of a given 
molecular character that is acquired following exposure to stress or stimuli, solely to 
epigenetic information rather than a subtle and perhaps hard to track change in the 
underlying genetic material. 
From a molecular view, classic epigenetic marks include DNA methylation and the 
modification of proteins that lie on or over the DNA sequence itself [2]. Chromatin and 
epigenetic are not, however, interchangeable terms.  Chromatin-based mechanisms of gene 
regulation are not necessarily epigenetic, at least not more than “classical” regulatory 
processes involving transcription factors. It is, again, a matter of heritability of a status in the 
absence of the original trigger. Epigenetics can also involve non-coding RNA molecules, 
small and long, providing they are passed from one cell to another or from one generation 
to the next to maintain phenotype [3]. There is, for example, limited argument to consider 
microRNAs, which control mRNA (and other types of RNA) stability and translation, as 
epigenetic regulators. Developmental epigenetics is not the study of these inherited factors 
per se, nor their global distribution across the genome, but is the study of the function of 
epigenetic processes during development, studies which may include the developmental 
programming of fetal growth trajectories and adult phenotypes.  
 
Functional epigenetics 
A key challenge in the discipline is directly linking changes in epigenetic marks with 
phenotypic outcomes. While there are numerous published studies on epigenetic 
differences between states, findings are correlative, and causality is not well established [4]. 
We can show that specific epigenetic modifications affect the accessibility of genomic 
regions such as promoters, preventing or allowing transcription factors or protein complexes 
to bind. This in turn can alter local chromatin structure or direct transcription. It is also 
possible to demonstrate experimentally that substantial changes in DNA methylation result 
in significant changes in gene transcription, fundamentally acting as on/off switches. 
Deletion of epigenetic regulators such as the DNA methyltransferases has profound 
consequences for gene transcription and development [5]. Epigenetic marks are also 
demonstrably critical for the formation and maintenance of heterochromatin [6], and for 
developmental processes such as X-chromosome inactivation [7] and genomic imprinting 
[8]. However, in each example multiple layers of epigenetic marks function as aggregates 
to control transcription. To what extent do small changes, even changes at single CpG sites 
or individual histone tails, have significant functional consequences that can be maintained 
and propagated upon division? A further question is the developmental relevance of 
epigenetic modifications that lie outside promoter or enhancer regions. Technologies such 
as next-generation sequencing (NGS) and single cell analysis enable us to quantify subtle 
epigenetic differences in great detail. However, new approaches are needed to alter single 
epigenetic modifications or subtly modify groups of marks in order to test their functional 
relevance.  In this respect, epi-editing holds great promise [9; 10]. Epigenetic modulators 
can be fused to catalytically inactive Cas9 (dCas9) or TALENs to enable targeted DNA 
methylation or histone modification, editing events that can drive the activation or silencing 
of a target locus or gene and, importantly, test the functional relevance of epigenetic marks 
over time. These strategies will be instrumental in addressing the consequences of 
transmitting epigenetic information across generations.  
 
 
Fetal programming 
A related challenge within the field of developmental epigenetics is understanding the link 
between early life exposures and later life outcomes. Human epidemiological studies have 
repeatedly linked adverse intrauterine and early postnatal events with subsequent obesity 
and metabolic disease as well as higher risk of a number of common mental health 
conditions – a phenomenon termed “fetal programming” [11] or developmental origins 
disease [12]. During development the epigenome undergoes extensive modification with 
epigenetic remodeling driving cellular differentiation to establish cell- and tissue-specific 
pattern of gene expression. Concurrently, in mammals the germline is undergoing waves of 
erasure and reestablishment of epigenetic marks to reprogram the epigenome for the next 
generation [13; 14; 15]. Epigenetic dysregulation had been proposed as a potential 
mechanism underlying anomalous fetal programming. It certainly fits the bill as epigenetic 
marks, unlike DNA sequence, are flexible and can be both added and removed within the 
cell cycle. Critically, epigenetic marks can be “remembered” for the full lifetime of the 
individual.  
 
In humans, numerous prenatal risk factors have been linked to poor health later in life 
including maternal nutrition and maternal stress [16; 17]. Early postnatal exposures such as 
the quality of maternal care can also influence later life outcomes, both negatively and 
positively [18]. Exposures rarely occur in isolation and there are different patterns and long-
term consequences of fetal adversities depending on the timing, nature and extent of the 
insult, as well as the gender of the exposed individual, adding an additional layer of 
complexity. In spite of species related differences, animal studies are important in clarifying 
causality, and exploring resilience, reversibility, temporal, tissue and gender specific 
sensitivities to different exposures. Even with everything we have learned about epigenetic 
processes, and despite hundreds of intervention studies, we still do not know definitively 
that epigenetic mechanisms are responsible for fetal programming. Critically, seemingly 
different exposures can have the same phenotypic outcome while the same exposure at a 
different time point or for a different duration can have a significantly different phenotypic 
outcome. One possible explanation is that specific and discrete regions of the developing 
epigenome are exquisitely sensitive to insults per se, and that windows of vulnerability vary 
with the developmental time point, between different tissues and between males and 
females. Excellent candidates for these sensitive regions are the imprinted genes. Imprinted 
genes are expressed predominantly from one parental allele as a consequence of 
epigenetic events initiated in the germline and built on in somatic cells to generate domains 
of allele-specific epigenetic modification and gene expression, some of which span many 
megabases [19]. Imprinted genes regulate fetal growth, placental development, postnatal 
metabolism and numerous complex mammalian behaviours [20]. Imprinted genes may not 
necessarily be more responsive to prenatal insults but small changes in their expression 
can have significant phenotypic consequences that persist into adulthood and imprinted 
genes expressed in one individual can even impact the behaviour of another individual [21; 
22]. Poor diet in pregnancy is already known to alter the epigenetic regulation of at least 
some of these remarkable genes [23].  
An interesting and related question is whether prenatal insults impact the activity of the X 
chromosomes in females, one of which in epigenetically inactivated. X-inactivation is set up 
early in utero and controls the expression dosage for most of the ~1000 genes that 
mammalian X chromosomes carry [24]. While female development cannot be pursued in 
the absence of X-inactivation, more subtle dosage aberrancy of particular X-linked genes 
may, as for imprinted genes, have long term phenotypic consequences, in a gender-specific 
manner. Comprehensive screens of the full range of early life challenges in one model 
organism under fully controlled conditions are required to test these hypotheses properly. 
Given extraordinary developments in next generation bisulphite sequencing technology, it 
is now possible to look both at tissue-specific epigenetic/transcriptional signatures and the 
signatures of specific cell types within tissues, including the potentially most vulnerable stem 
cell populations. Developments in imaging technologies will also provide a new platform for 
these types of study increasing our capacity to detect subtle changes in gene expression 
[23]. Descriptions of epigenetic alterations alone, however, are not sufficient. Linking specific 
gene changes to phenotype is essential. 
 Epigenetics and adaptation 
A third challenge is understanding the role of epigenetic marks in environmental adaptations, 
and, as an extension of this concept – in evolution. Normally we view alterations in 
epigenetic marks as a negative outcome (epimutations), for example in case of certain 
cancers or the imprinting disorders. However, epigenetic flexibility may contribute to 
enhanced survival under different environmental conditions. There are examples of this in 
plants [25] and some lower animals [26] but again, the challenge is establishing cause and 
effect relationships. Unless reproduction is clonal in the wild, there are both genetic and 
epigenetic differences. Over 200 years ago Jean Baptiste Lamarck (1744-1829) proposed 
that environmental factors could lead to the increase or decrease of a particular structure 
and be passed on to offspring, giving the example of a giraffe stretching its neck to reach 
the juiciest leaves at the top of trees and then giving birth to progeny with similarly long 
necks [27] (Figure 1). His theories contributed to the onset of Darwinism but were largely 
derided at the time. Now that we know epigenetic marks can respond to the environment 
and may not be fully erased in the germline, Lamarck’s ideas are no longer quite so easily 
dismissed. 
 
Summary 
In summary, a key area of focus for this specialty section on developmental epigenetics is 
understanding the functional relevance of both large and small changes in epigenetic marks 
in development and beyond. Connected with this work are studies investigating how early 
environmental exposures modulate epigenetic marks to alter later life phenotypes, with a 
critical emphasis on studies that establish causality. Finally, it is important to consider how 
epigenetic processes have contributed to evolution. Frontiers in Cell and Developmental 
Biology will serve as an important platform for studies in these areas and, like the epigenome, 
we will be flexible in response to our environment cues (the epigenetics community) to take 
on emerging themes. 
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Figure 1. An update on Larmarck’s giraffes. 
